NewAmsterdam Pharma
NAMS
NAMS
76 hedge funds and large institutions have $1.71B invested in NewAmsterdam Pharma in 2024 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
5.6% more ownership
Funds ownership: 75.23% → 80.82% (+5.6%)
Holders
76
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$30.4M | |
| 2 | +$25.4M | |
| 3 | +$18.9M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$16.2M |
| 5 |
DM
Deerfield Management
New York
|
+$13.5M |
Top Sellers
| 1 | -$8.94M | |
| 2 | -$7.68M | |
| 3 | -$2.05M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$2.04M |
| 5 |
Axa
Paris,
France
|
-$550K |